Fast Market Research

Antigen Express, Inc. - Product Pipeline Review - 2013 - New Report Available

New Pharmaceuticals market report from Global Markets Direct: "Antigen Express, Inc. - Product Pipeline Review - 2013"


Boston, MA -- (SBWIRE) -- 07/08/2013 -- Global Market Direct's pharmaceuticals report, "Antigen Express, Inc. - Product Pipeline Review - 2013" provides data on the Antigen Express, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Antigen Express, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Antigen Express, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.


- Antigen Express, Inc. - Brief Antigen Express, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Antigen Express, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Antigen Express, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Antigen Express, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate Antigen Express, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Antigen Express, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Antigen Express, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Antigen Express, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Antigen Express, Inc. and identify potential opportunities in those areas.

Companies Mentioned in this Report: Antigen Express, Inc.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Antigen Express, Inc. - Product Pipeline Review - 2012
- Generex Biotechnology Corporation - Product Pipeline Review - 2013
- Anthrax - Pipeline Review, H1 2013
- Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2013
- Melanoma - Pipeline Review, H1 2013
- Malignant Mesothelioma - Pipeline Review, H1 2013
- HIV / AIDS - Pipeline Review, H1 2013
- Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2013
- Inflammatory Pain - Pipeline Review, H1 2013
- Muscle Wasting Disorders - Pipeline Review, H1 2013